Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469521 · ClinicalTrials.gov registry record · Phase 4
Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00469521 is a Phase 4 study that has completed, run by Innovative Medical.
The verdict
NCT00469521, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.
Interventions
- DRUG Refresh Tears, 9582X
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00469521
The ClinicalTrials.gov registry entry for NCT00469521 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Refresh Tears, 9582X is the first listed.
NCT00469521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00469521 about?
NCT00469521 is a clinical study titled "Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness". To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.
What is the current status of trial NCT00469521?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00469521?
The interventions under investigation include: Refresh Tears, 9582X (DRUG).
Who is sponsoring clinical trial NCT00469521?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.